跳至主要内容
临床试验/NCT02509000
NCT02509000已完成不适用

Beijing Indoor Air Purifier Intervention Study

WeiHuang0 个研究点目标入组 35 人开始时间: 2013年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
35
主要终点
respiratory inflammation

研究概览

简要总结

This study aimed to assess the impact of air filtration on indoor air quality and cardio-pulmonary health in residents living in high outdoor pollution settings in Beijing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Health Services Research
盲法
Double (Participant, Investigator)

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Global Initiative for Chronic Obstructive Lung Disease criteria (mild to moderate, GOLD stage I~II;
  • severe to very severe, GOLD stage III~IV) quit smoking for at least 1 year;
  • a ratio of pre-bronchodilator forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) equal to or less than 0.70 and an increase of FEV1 with the use of 400μg of albuterol of less than 12% of the pre-bronchodilator one;
  • no history of asthma or any other active lung disease.
  • Subjects were free from exacerbations for at least 6 weeks.

排除标准

  • Patients with heart pacemaker,
  • heart failure with bundle-branch block,
  • recent myocardial infarction (in the last 12 weeks) and
  • anticoagulant therapy

结局指标

主要结局

respiratory inflammation

时间窗: 4 weeks

analyzed EBC pH and inflammation biomarkers 8-isoprostane and nitrite and nitrate

次要结局

  • oxidative stress(4 weeks)
  • systemic inflammation(4 weeks)

研究者

发起方
WeiHuang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

WeiHuang

Peking University School of Public Health

Peking University

相似试验